Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease-Reference-Cited by-同舟云学术

Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease

Published:2018-03-23 Issue:6 Volume:33 Page:928-936
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Fernandez Hubert H.¹,Boyd James T.²,Fung Victor S. C.³,Lew Mark F.⁴,Rodriguez Ramon L.⁵,Slevin John T.⁶,Standaert David G.⁷^ORCID,Zadikoff Cindy⁸,Vanagunas Arvydas D.⁸,Chatamra Krai⁹,Eaton Susan⁹,Facheris Maurizio F.⁹,Hall Coleen⁹,Robieson Weining Z.⁹,Benesh Janet⁹,Espay Alberto J.¹⁰^ORCID

Affiliation:

1. Center for Neurological Restoration; Cleveland Clinic; Cleveland Ohio USA

2. University of Vermont Larner College of Medicine, Burlington; Vermont USA

3. Westmead Hospital and Sydney Medical School; Sydney Australia

4. Keck/University of Southern California School of Medicine; Los Angeles California USA

5. University of Florida College of Medicine, Gainesville, Florida, USA, and Orlando Veterans Affairs Medical Center; Orlando Florida USA

6. University of Kentucky Medical Center; Lexington Kentucky USA

7. University of Alabama at Birmingham; Birmingham; Alabama USA

8. Feinberg School of Medicine; Northwestern University; Chicago Illinois USA

9. AbbVie Inc.; North Chicago Illinois USA

10. University of Cincinnati Academic Health Center; Cincinnati Ohio USA

Funder